CLINICAL TRIAL
Treatment for Osteoporosis, Age Related
Recruiting · 18+ · All Sexes · Lexington, KY
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
See full descriptionAbout the trial for Osteoporosis, Age Related
Eligible Conditions
Osteoporosis, Age Related · Osteoporosis
Treatment Groups
This trial involves 3 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 4 and have been shown to be safe and effective in humans.
Control Group 1
Teriparatide
DRUG
Control Group 2
Alendronate
DRUG
Control Group 3
Alendronate
DRUG
Eligibility
This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.
Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:View All
The person has been diagnosed with osteoporosis by means of a DXA scan (a scan that measures bone mineral density) which showed that their bone mineral density was less than 2.5 standard deviations below the average for their sex and age show original
Age ≥ 40 years;
Females;
oys
The absence of alloys means that pure metals are used show original
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Approximate Timelines
Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 1 Year
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like
Measurement Requirements
This trial is evaluating whether Treatment will improve 2 primary outcomes in patients with Osteoporosis, Age Related. Measurement will happen over the course of 1 Year.
Mineral Bone Density of the lumbar spine
1 YEAR
Percent change in mineral bone density absolute values of the lumbar spine measured by DXA at baseline and at one year.Measure of serum osteocalcin levels to predict bone turnover
1 YEAR
Diagnostic Utility of serum osteocalcin level measurements by ELISA at baseline and at one year to predict bone turnover. Area under the receiver operating characteristic curve analysis will be used to determine the discriminative power of osteocalcin levels for determination of low versus non-low bone turnover.Patient Q & A Section
Ask a question about the study
Other questions from users
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any geographic restrictions to consider when applying for this trial?
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
Will my insurance cover participating in this trial?
In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.
See if you qualify for this trial
Get access to this novel treatment for Osteoporosis, Age Related by sharing your contact details with the study coordinator.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Power